JP2010523264A5 - - Google Patents

Download PDF

Info

Publication number
JP2010523264A5
JP2010523264A5 JP2010503052A JP2010503052A JP2010523264A5 JP 2010523264 A5 JP2010523264 A5 JP 2010523264A5 JP 2010503052 A JP2010503052 A JP 2010503052A JP 2010503052 A JP2010503052 A JP 2010503052A JP 2010523264 A5 JP2010523264 A5 JP 2010523264A5
Authority
JP
Japan
Prior art keywords
heart
pattern
composition
occlusive agent
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010503052A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010523264A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/004613 external-priority patent/WO2008127607A2/en
Publication of JP2010523264A publication Critical patent/JP2010523264A/ja
Publication of JP2010523264A5 publication Critical patent/JP2010523264A5/ja
Pending legal-status Critical Current

Links

JP2010503052A 2007-04-11 2008-04-10 心臓の静脈系を用いた心臓の修復、リサイジング、およびリシェイピング Pending JP2010523264A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US92293007P 2007-04-11 2007-04-11
US93404207P 2007-06-11 2007-06-11
US93411107P 2007-06-11 2007-06-11
US93410907P 2007-06-11 2007-06-11
PCT/US2008/004613 WO2008127607A2 (en) 2007-04-11 2008-04-10 Cardiac repair, resizing and reshaping using the venous system of the heart

Publications (2)

Publication Number Publication Date
JP2010523264A JP2010523264A (ja) 2010-07-15
JP2010523264A5 true JP2010523264A5 (enExample) 2011-05-19

Family

ID=39864585

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010503052A Pending JP2010523264A (ja) 2007-04-11 2008-04-10 心臓の静脈系を用いた心臓の修復、リサイジング、およびリシェイピング

Country Status (6)

Country Link
US (2) US7875017B2 (enExample)
EP (1) EP2146667A2 (enExample)
JP (1) JP2010523264A (enExample)
AU (1) AU2008239681B2 (enExample)
CA (1) CA2682160C (enExample)
WO (1) WO2008127607A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007292923B2 (en) * 2006-09-08 2013-10-03 Cardiopolymers, Inc. Intramyocardial patterning for global cardiac resizing and reshaping
CA2682160C (en) 2007-04-11 2017-04-04 Henry Ford Health System Cardiac repair, resizing and reshaping using the venous system of the heart
WO2008154033A2 (en) * 2007-06-11 2008-12-18 Symphony Medical, Inc. Cardiac patterning for improving diastolic function
US9238046B2 (en) 2007-09-21 2016-01-19 The Trustees Of The University Of Pennsylvania Prevention of infarct expansion
US20090259210A1 (en) * 2008-04-10 2009-10-15 Sabbah Hani N Method, apparatus and kits for forming structural members within the cardiac venous system
AU2009289484B2 (en) * 2008-09-05 2014-10-23 Cardiopolymers, Inc Apparatus and method for capsule formation in tissue
ES2628100T3 (es) 2008-09-30 2017-08-01 The Regents Of The University Of California Composiciones que comprenden matriz extracelular descelularizada obtenida a partir de tejido cardíaco
EP2345433B1 (en) 2008-10-06 2017-03-01 3-D Matrix, Ltd. Tissue plug
US10143455B2 (en) 2011-07-20 2018-12-04 Covidien LLP Enhanced ultrasound visualization of intravascular devices
CN105212984B (zh) 2009-02-20 2017-12-22 柯惠有限合伙公司 用于治疗静脉机能不全的静脉闭塞的方法和装置
JP2013536246A (ja) 2010-08-24 2013-09-19 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 心臓治療のための組成物及び方法
WO2013036708A2 (en) 2011-09-07 2013-03-14 The Regents Of The University Of California Compositions and methods for tissue repair with extracellular matrices
US9168352B2 (en) 2011-12-19 2015-10-27 Cardiacassist, Inc. Dual lumen cannula
US8808620B1 (en) 2012-02-22 2014-08-19 Sapheon, Inc. Sterilization process design for a medical adhesive
JP6389170B2 (ja) 2012-07-06 2018-09-12 スリーディー マトリックス， エルティーディー３−Ｄ Ｍａｔｒｉｘ， Ｌｔｄ． ペプチド溶液のためのフィル−フィニッシュ過程
JP6684719B2 (ja) 2014-03-10 2020-04-22 株式会社スリー・ディー・マトリックス ペプチド組成物の滅菌および濾過
CA2939696C (en) 2014-03-10 2023-01-10 3-D Matrix, Ltd. Self-assembling peptide compositions
EP3119448B1 (en) 2014-03-21 2020-04-22 University of Pittsburgh- Of the Commonwealth System of Higher Education Methods for preparation of a terminally sterilized hydrogel derived from extracellular matrix
WO2017120092A1 (en) 2016-01-06 2017-07-13 3-D Matrix, Ltd. Combination compositions
AU2017207015B2 (en) 2016-01-13 2022-08-04 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Vascular extracellular matrix hydrogel
EP3709930A4 (en) * 2017-11-17 2021-09-01 Arizona Board of Regents on behalf of the University of Arizona Scaffolds having material properties optimized for cardiac applications and uses thereof
BR112021004964A2 (pt) * 2018-11-07 2021-06-08 Baxter International Inc. aplicador com uma só mão com válvula de detenção dupla
US20240299018A1 (en) * 2023-03-07 2024-09-12 Medtronic, Inc. Occlusion device

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5328471A (en) 1990-02-26 1994-07-12 Endoluminal Therapeutics, Inc. Method and apparatus for treatment of focal disease in hollow tubular organs and other tissue lumens
US6132451A (en) 1995-06-07 2000-10-17 Eclipse Surgical Technologies, Inc. Optical fiber for myocardial channel formation
US6283951B1 (en) 1996-10-11 2001-09-04 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
WO1997016169A1 (en) 1995-11-01 1997-05-09 Chiron Corporation Treatment of a cardiovascular indication by delivery of therapeutics to the pericardial space
EP1707233A3 (en) 1996-02-02 2006-12-20 Medtronic Vascular, Inc. Apparatus for blocking flow through blood vessels
IL118376A0 (en) 1996-05-22 1996-09-12 Univ Ben Gurion Polysaccharide sponges for cell culture and transplantation
US6063061A (en) 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
WO1998012274A1 (en) 1996-09-23 1998-03-26 Chandrashekar Pathak Methods and devices for preparing protein concentrates
US7883539B2 (en) 1997-01-02 2011-02-08 Edwards Lifesciences Llc Heart wall tension reduction apparatus and method
US6406420B1 (en) 1997-01-02 2002-06-18 Myocor, Inc. Methods and devices for improving cardiac function in hearts
US6183411B1 (en) 1998-09-21 2001-02-06 Myocor, Inc. External stress reduction device and method
US6077214A (en) 1998-07-29 2000-06-20 Myocor, Inc. Stress reduction apparatus and method
US6045565A (en) 1997-11-04 2000-04-04 Scimed Life Systems, Inc. Percutaneous myocardial revascularization growth factor mediums and method
US6511477B2 (en) 1997-03-13 2003-01-28 Biocardia, Inc. Method of drug delivery to interstitial regions of the myocardium
EP0980428A2 (en) 1997-05-06 2000-02-23 The Regents Of The University Of California TECHNIQUES AND COMPOSITIONS FOR TREATING HEART FAILURE AND VENTRICULAR REMODELING BY $i(IN VIVO) DELIVERY OF ANGIOGENIC TRANSGENES
US7031775B2 (en) 1997-11-07 2006-04-18 Medtronic, Inc. Method and system for myocardial infarction repair
US6096021A (en) 1998-03-30 2000-08-01 The University Of Virginia Patent Foundation Flow arrest, double balloon technique for occluding aneurysms or blood vessels
US6085754A (en) 1998-07-13 2000-07-11 Acorn Cardiovascular, Inc. Cardiac disease treatment method
US6547821B1 (en) 1998-07-16 2003-04-15 Cardiothoracic Systems, Inc. Surgical procedures and devices for increasing cardiac output of the heart
US6360749B1 (en) 1998-10-09 2002-03-26 Swaminathan Jayaraman Modification of properties and geometry of heart tissue to influence heart function
US6685627B2 (en) * 1998-10-09 2004-02-03 Swaminathan Jayaraman Modification of properties and geometry of heart tissue to influence heart function
AU2707500A (en) 1998-12-04 2000-06-26 Incept Llc Biocompatible crosslinked polymers
US6689103B1 (en) 1999-05-07 2004-02-10 Scimed Life System, Inc. Injection array apparatus and method
US20030113301A1 (en) 1999-07-23 2003-06-19 Albert Edge Muscle cells and their use in cardiac repair
US6673604B1 (en) 1999-07-23 2004-01-06 Diacrin, Inc. Muscle cells and their use in cardiac repair
US6709427B1 (en) 1999-08-05 2004-03-23 Kensey Nash Corporation Systems and methods for delivering agents into targeted tissue of a living being
US6926689B2 (en) 2002-03-13 2005-08-09 Albertus Scheule Aortic balloon occlusion cannula
US6575932B1 (en) 1999-12-02 2003-06-10 Ottawa Heart Institute Adjustable multi-balloon local delivery device
CN1227004C (zh) 2000-02-18 2005-11-16 Cv治疗公司 治疗充血性心力衰竭的部分脂肪酸氧化抑制剂
US6508824B1 (en) 2000-02-18 2003-01-21 Transvascular, Inc. Catheter-based methods for enlarging blood vessels to facilitate the formation of penetration tracts, fistulas and/or blood flow channels
US6537198B1 (en) 2000-03-21 2003-03-25 Myocor, Inc. Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly
US6585716B2 (en) 2000-04-05 2003-07-01 Biocardia, Inc. Method of treating the heart
US6730016B1 (en) 2000-06-12 2004-05-04 Acorn Cardiovascular, Inc. Cardiac disease treatment and device
AU2001286613A1 (en) 2000-08-21 2002-03-04 Rice University Tissue engineering scaffolds promoting matrix protein production
US7491385B2 (en) 2001-09-05 2009-02-17 Genegrafts Ltd. Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
US20020077687A1 (en) 2000-12-14 2002-06-20 Ahn Samuel S. Catheter assembly for treating ischemic tissue
US6620095B2 (en) 2000-12-22 2003-09-16 Syde A. Taheri Cradle-assisted myocardial repair and treatment
US7740623B2 (en) 2001-01-13 2010-06-22 Medtronic, Inc. Devices and methods for interstitial injection of biologic agents into tissue
AU2002249947A1 (en) 2001-01-15 2002-07-30 Henry Ford Health System Inhibition of protein-phosphatases for the treatment of heart failure
US20030211793A1 (en) 2001-03-05 2003-11-13 Eugene Bell Injectable bio-compatible material and methods of use
US20020188170A1 (en) 2001-04-27 2002-12-12 Santamore William P. Prevention of myocardial infarction induced ventricular expansion and remodeling
CA2821193C (en) * 2001-04-27 2015-09-08 Satterfield, Richard C. Prevention of myocardial infarction induced ventricular expansion and remodeling
US7311731B2 (en) 2001-04-27 2007-12-25 Richard C. Satterfield Prevention of myocardial infarction induced ventricular expansion and remodeling
EP1412023A4 (en) 2001-07-16 2009-12-02 Corassist Cardiovascular Ltd METHOD AND DEVICE IN-VIVO FOR IMPROVING THE DIASTOLIC FUNCTION OF THE LEFT VENTRICLE
US6962588B2 (en) 2001-08-31 2005-11-08 Boston Scientific Scimed, Inc. Percutaneous pringle occlusion method and device
WO2003024462A1 (en) 2001-09-19 2003-03-27 Henry Ford Health System Cardiac transplantation of stem cells for the treatment of heart failure
JP2005527482A (ja) 2001-11-08 2005-09-15 ザ レジェンツ オブ ザ ユニバーシティー オブ カリフォルニア サン ディエゴ 心臓伝導障害の矯正のための方法および組成物
US20040106896A1 (en) 2002-11-29 2004-06-03 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
WO2003094697A2 (en) 2002-05-08 2003-11-20 The Regents Of The University Of California Methods and compositions for correction of cardiac conduction disturbances
CA2487254A1 (en) 2002-05-08 2003-11-20 The Regents Of The University Of California System and method for treating cardiac arrhythmias with fibroblast cells
AU2003239418B2 (en) 2002-05-08 2008-01-31 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
AU2003272951A1 (en) * 2002-11-19 2004-06-15 Nihon University Balloon catheter and device for injecting medical treatment method
US20060241334A1 (en) 2003-01-27 2006-10-26 Corassist Cardiovascular Ltd. In vivo device for improving diastolic ventricular function
US7840262B2 (en) 2003-03-10 2010-11-23 Impulse Dynamics Nv Apparatus and method for delivering electrical signals to modify gene expression in cardiac tissue
US8383158B2 (en) 2003-04-15 2013-02-26 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
MXPA05011896A (es) 2003-05-05 2006-05-25 Univ Ben Gurion Preparaciones polimericas reticuladas inyectables y sus usos.
EP1786502A2 (en) 2004-07-15 2007-05-23 Incumed Device and method for treating a blood vessel
SG156681A1 (en) 2004-11-09 2009-11-26 Cv Therapeutics Inc Use of ranolazine in combination with at least one remodeling agent for reversing left ventricular remodeling in the treatment of heart failure
US7226440B2 (en) 2005-01-31 2007-06-05 G & L Consulting, Llc Method and device for accessing a pericardial space
US8303972B2 (en) 2005-04-19 2012-11-06 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
US20060253068A1 (en) 2005-04-20 2006-11-09 Van Bilsen Paul Use of biocompatible in-situ matrices for delivery of therapeutic cells to the heart
US20070093748A1 (en) 2005-06-23 2007-04-26 Medtronic Vascular, Inc. Methods and systems for treating injured cardiac tissue
US20070172472A1 (en) 2005-06-23 2007-07-26 Asha Nayak Methods and Systems for Treating Injured Cardiac Tissue
WO2007002554A2 (en) 2005-06-23 2007-01-04 Medtronic Vascular, Inc. Methods and systems for treating injured cardiac tissue
US20070100199A1 (en) * 2005-11-03 2007-05-03 Lilip Lau Apparatus and method of delivering biomaterial to the heart
EP2032149A4 (en) 2006-06-13 2010-09-01 Fmc Biopolymer As METHOD AND SYSTEMS FOR THE USE OF BIOPOLYMER-BASED BEADS AND HYDROGELS
AU2007292923B2 (en) 2006-09-08 2013-10-03 Cardiopolymers, Inc. Intramyocardial patterning for global cardiac resizing and reshaping
CA2682160C (en) 2007-04-11 2017-04-04 Henry Ford Health System Cardiac repair, resizing and reshaping using the venous system of the heart
US20090259210A1 (en) 2008-04-10 2009-10-15 Sabbah Hani N Method, apparatus and kits for forming structural members within the cardiac venous system

Similar Documents

Publication Publication Date Title
JP2010523264A5 (enExample)
JP2010502371A5 (enExample)
US20070042016A1 (en) Methods and Systems for Treating Injured Cardiac Tissue
US20070093748A1 (en) Methods and systems for treating injured cardiac tissue
Hughes et al. Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF
JP5522664B2 (ja) 全体的な心臓のサイズ変更および再形成のための心筋内パターン形成
US20070172472A1 (en) Methods and Systems for Treating Injured Cardiac Tissue
CN107049232B (zh) 一种贴附式心脏功能监测和/或干预系统
US20100280493A1 (en) Methods and Systems for Treating Injured Cardiac Tissue
JP2004337400A (ja) 薬剤投与キット
JP2010502369A5 (enExample)
US20100152531A1 (en) Implantable medical device for drug delivery and method of use
US11197944B2 (en) Compositions and methods of mechanically inducing tissue regeneration
Bahramian et al. The effects of exercise training intensity on the expression of C/EBPβ and CITED4 in rats with myocardial infarction
CN101229366B (zh) 成纤维细胞生长因子在制备促进血管生成药物中的应用
WO2007112135A2 (en) Methods and systems for treating injured cardiac tissue
CN1250287C (zh) 一种重组腺病毒在脑缺血、创伤修复和组织粘连治疗中的应用
CN206424057U (zh) 一种贴附式心脏功能监测和/或干预系统
CN119080908B (zh) 一种预防或治疗心肌缺血再灌注损伤的多肽及其应用
CN118787731B (zh) Ptma短肽在制备心梗治疗药物中的应用
US20220288369A1 (en) Targeted drug delivery devices and methods
EP1912594A2 (en) Methods and systems for treating injured cardiac tissue
RU2538044C1 (ru) Способ защиты миокарда во время операции протезирования аортального клапана в условиях искусственного кровообращения
JP2009120625A (ja) 安定したｔ３の組成物およびその使用方法
Matsusaka et al. Target deletion of matrix metalloproteinase-2 attenuates cardiac remodeling and failure in mice with chronic pressure overload